General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

quit-cardsDecember 8 2014

Independent community pharmacies can place orders for the NHS Quit Card which will form part of the new Smokefree January campaign.

Both the National Pharmacy Association and the Royal Pharmaceutical Society are encouraging involvement in the Public Health England campaign.

The NPA says: “The cards are designed to help pharmacy teams in England engage their customers in conversation about smoking cessation and aim to help customers:

•    identify their level of addiction
•    understand how their local pharmacy team can help support them give up
•    find the right free Smokefree support tool for them.”

Alongside the NHS Quit Cards is the newly developed Advisor Guide. The RPS describes this as “an easy-to-use reference tool which pharmacy staff can keep with them and use when engaging smokers. It includes help on how pharmacy staff can tailor their advice to the addiction test results and the key benefits of the Smokefree support tools.

Quit Cards will be provided to pharmacies free of charge and can be ordered in a kit containing 50 Quit Cards and point-of-sale material by calling 0300 123 1019.

“The order line will be open Monday to Friday, from 8am to 6pm, until March 26 2015 or whilst stocks last. If you are a large multiple pharmacy or part of a small chain of pharmacies, please check with your head office as we may already be liaising with your organisation,” adds the RPS.


Links:

NPA statement

RPS statement

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...